ior c5 (The Center of Molecular Immunology)

N/A

Report date: 2025/11/24 17:58:18

Base Information

Drug Nameior c5 (The Center of Molecular Immunology)
Drug Alias NameIOR-C5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineRadiation-emitting products > Radioactive therapeutic agent +[5
Mechanisms of ActionImmunoglobulin G modulators
TargetsImmunoglobulin G
Therapy Area/IndicationsOvarian NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A